How COVID-19 Has Changed the Management of Glomerular Diseases.
作者信息
Bomback Andrew S, Canetta Pietro A, Ahn Wooin, Ahmad Syeda B, Radhakrishnan Jai, Appel Gerald B
机构信息
The Center for Glomerular Diseases, Division of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York City, New York.
出版信息
Clin J Am Soc Nephrol. 2020 Jun 8;15(6):876-879. doi: 10.2215/CJN.04530420. Epub 2020 Apr 24.
Abstract
摘要
相似文献
1
How COVID-19 Has Changed the Management of Glomerular Diseases.新冠疫情如何改变了肾小球疾病的管理
Clin J Am Soc Nephrol. 2020 Jun 8;15(6):876-879. doi: 10.2215/CJN.04530420. Epub 2020 Apr 24.
2
Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus Pandemic.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行期间肾移植受者的门诊管理
Clin J Am Soc Nephrol. 2020 Jun 8;15(6):892-895. doi: 10.2215/CJN.04510420. Epub 2020 Apr 28.
3
COVID-19 in Children with Nephrotic Syndrome on Anti-CD20 Chronic Immunosuppression.接受抗CD20慢性免疫抑制治疗的肾病综合征患儿的新型冠状病毒肺炎
Clin J Am Soc Nephrol. 2020 Oct 7;15(10):1494-1495. doi: 10.2215/CJN.06400420. Epub 2020 Jul 10.
4
Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern Italy.意大利北部严重急性呼吸综合征冠状病毒2疫情期间炎症性肠病患者的平稳病程
Gastroenterology. 2020 Jul;159(1):371-372. doi: 10.1053/j.gastro.2020.03.062. Epub 2020 Apr 2.
5
The Early Days: The Postkidney Transplant Recipients' COVID-19 Journey.早期：肾移植受者的新冠疫情经历
Clin J Am Soc Nephrol. 2020 Sep 7;15(9):1221-1223. doi: 10.2215/CJN.08780620. Epub 2020 Jul 29.
6
COVID-19-related Mortality During the First 60 Days After Kidney Transplantation.肾移植后前60天内与COVID-19相关的死亡率
Eur Urol. 2020 Oct;78(4):641-643. doi: 10.1016/j.eururo.2020.06.036. Epub 2020 Jun 19.
7
Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician.冠状病毒与炎症性肠病患者：临床医生的管理策略
Am J Gastroenterol. 2020 Oct;115(10):1566-1569. doi: 10.14309/ajg.0000000000000817.
8
COVID-19 in a Kidney Transplant Patient.一名肾移植患者的新型冠状病毒肺炎
Eur Urol. 2020 Jun;77(6):769-770. doi: 10.1016/j.eururo.2020.03.036. Epub 2020 Apr 6.
9
Coronavirus Disease (COVID-19) in Kidney and Liver Transplant Patients: A Single-Center Experience.肾移植和肝移植患者中的冠状病毒病（COVID-19）：单中心经验
Exp Clin Transplant. 2020 Jun;18(3):270-274. doi: 10.6002/ect.2020.0193.
10
COVID-19 and cancer: do we really know what we think we know?COVID-19 与癌症：我们真的了解我们自以为了解的吗？
Nat Rev Clin Oncol. 2020 Jul;17(7):386-388. doi: 10.1038/s41571-020-0394-y.
引用本文的文献
1
The impact of SARS-CoV-2 infection on renal function in patients with biopsy-proven kidney diseases.SARS-CoV-2 感染对经肾活检证实的肾脏病患者肾功能的影响。
PLoS One. 2023 Dec 22;18(12):e0296168. doi: 10.1371/journal.pone.0296168. eCollection 2023.
2
Outcome of Therapies for Membranous Glomerulonephritis During Three Waves of COVID Pandemic.新冠疫情三波期间膜性肾小球肾炎的治疗结果
Indian J Nephrol. 2023 Jul-Aug;33(4):289-291. doi: 10.4103/ijn.ijn_162_22. Epub 2023 Mar 8.
3
Current Understanding of Clinical Manifestations of COVID-19 in Glomerular Disease.新型冠状病毒肺炎合并肾小球疾病临床表现的当前认识
Glomerular Dis. 2021 Jul 8;1(4):250-264. doi: 10.1159/000518276. eCollection 2021 Oct.
4
Characteristics of SARS-CoV-2 Infection in an Actively Monitored Cohort of Patients with Lupus Nephritis.狼疮性肾炎患者主动监测队列中新型冠状病毒肺炎感染的特征
Biomedicines. 2022 Sep 28;10(10):2423. doi: 10.3390/biomedicines10102423.
5
Impact of COVID 19 pandemic on patients requiring renal biopsy.COVID-19 大流行对需要肾活检患者的影响。
Int Urol Nephrol. 2022 Oct;54(10):2617-2623. doi: 10.1007/s11255-022-03162-z. Epub 2022 Mar 15.
6
Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19.肾小球疾病中的免疫抑制：对严重急性呼吸综合征冠状病毒2疫苗和冠状病毒病的影响
Glomerular Dis. 2021 Aug 25;1(4):277-293. doi: 10.1159/000519182. eCollection 2021 Oct.
7
Membranous nephropathy in a patient with COVID-19 infection.一名新冠肺炎感染患者的膜性肾病
J Nephrol. 2022 Jan;35(1):351-355. doi: 10.1007/s40620-021-01165-0. Epub 2021 Oct 7.
8
COVID-19 associated thromboinflammation of renal capillary: potential mechanisms and treatment.新型冠状病毒肺炎相关的肾毛细血管血栓性炎症：潜在机制与治疗
Am J Transl Res. 2020 Dec 15;12(12):7640-7656. eCollection 2020.
9
Management of Canadian Pediatric Patients With Glomerular Diseases During the COVID-19 Pandemic: Recommendations From the Canadian Association of Pediatric Nephrologists COVID-19 Rapid Response Team.COVID-19大流行期间加拿大儿童肾小球疾病患者的管理：加拿大儿科肾脏病学家协会COVID-19快速反应小组的建议
Can J Kidney Health Dis. 2020 Nov 13;7:2054358120970713. doi: 10.1177/2054358120970713. eCollection 2020.
10
Ethics of kidney care in the era of COVID-19.COVID-19 时代的肾脏护理伦理。
Kidney Int. 2020 Dec;98(6):1424-1433. doi: 10.1016/j.kint.2020.09.014. Epub 2020 Oct 7.
本文引用的文献
1
Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York.纽约肾移植受者中 2019 年冠状病毒疾病的早期描述。
J Am Soc Nephrol. 2020 Jun;31(6):1150-1156. doi: 10.1681/ASN.2020030375. Epub 2020 Apr 21.
2
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
3
Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19.在对COVID-19中的RAS阻断进行快速判断之前的可靠科学依据。
Clin J Am Soc Nephrol. 2020 May 7;15(5):714-716. doi: 10.2215/CJN.03530320. Epub 2020 Mar 27.
4
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.肾素-血管紧张素系统阻滞剂与 COVID-19 大流行：目前尚无证据表明应放弃使用肾素-血管紧张素系统阻滞剂。
Hypertension. 2020 Jun;75(6):1382-1385. doi: 10.1161/HYPERTENSIONAHA.120.15082. Epub 2020 Mar 25.
5
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.血浆置换联合糖皮质激素治疗重症 ANCA 相关性血管炎。
N Engl J Med. 2020 Feb 13;382(7):622-631. doi: 10.1056/NEJMoa1803537.
6
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.利妥昔单抗或环孢素治疗膜性肾病。
N Engl J Med. 2019 Jul 4;381(1):36-46. doi: 10.1056/NEJMoa1814427.
7
Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.使用磷脂酶 A2 受体抗体进行原发性膜性肾病的无创诊断。
Kidney Int. 2019 Feb;95(2):429-438. doi: 10.1016/j.kint.2018.10.021.
8
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.口服甲泼尼龙对IgA肾病患者临床结局的影响：TESTING随机临床试验
JAMA. 2017 Aug 1;318(5):432-442. doi: 10.1001/jama.2017.9362.
9
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.IgA 肾病的强化支持治疗加免疫抑制。
N Engl J Med. 2015 Dec 3;373(23):2225-36. doi: 10.1056/NEJMoa1415463.
Zotero 插件